# **Strategic Market Analysis: Global Longevity, Preventive Health, and Consumer Health-Tech Opportunities (2026 Outlook)**

## **1\. Executive Summary: The Structural Shift to Quantified Longevity**

As the global economy stabilizes in early 2026, the longevity and preventive health sectors have transitioned from niche, speculative markets into foundational pillars of the consumer economy. The convergence of post-pandemic health consciousness, the democratization of metabolic therapies—most notably GLP-1 agonists—and the maturation of biosensor technology has created a "Longevity Economy" projected to impact global GDP by upwards of $27 trillion over the coming decade.1 For a solo developer based in France with advanced technical capabilities in AI, OCR, and data engineering, this environment presents a rare and asymmetrical opportunity. The market is no longer constrained by a lack of consumer interest but by a profound failure of infrastructure: users possess an abundance of health data yet lack the interoperable, privacy-preserving tools required to synthesize it into actionable intelligence.  
The analysis indicates that the era of "wellness fluff"—vague lifestyle apps with little scientific grounding—is collapsing under the weight of consumer skepticism and economic pragmatism. It is being replaced by a demand for "hard" health tech: tools that manage medication protocols, normalize complex blood biomarkers, and provide granular, owned data insights.2 The incumbent players, ranging from legacy heavyweights like WeightWatchers to tech giants like Apple and Garmin, are structurally impeded by their business models. They are incentivized to build "walled gardens" that trap data, whereas the 2026 consumer is actively seeking "universal adapters" and "local-first" privacy solutions.4  
This report evaluates the global landscape to determine the viability of entering the longevity space as a solo developer. The conclusion is affirmative, provided the developer avoids direct competition with platform ecosystems and instead focuses on the high-value "middleware" of health. The most potent opportunities lie in unsexy, utility-driven micro-SaaS products that solve specific technical frictions: the parsing of PDF medical records, the privacy-compliant aggregation of wearable data, and the specialized management of GLP-1 therapeutic lifestyles. By leveraging a "Local-First" software architecture, a solo developer can bypass the crippling server costs and regulatory liabilities that hamstring larger competitors, creating a lean, high-margin business that services the growing class of "Pro-sumer" patients.6

## **2\. Market Discovery: Global Dynamics and Emerging User Segments**

To identify where a solo developer can compete, one must first dissect the macroeconomic and behavioral shifts defining 2026\. The market is not a monolith; it is a fragmented landscape where specific sub-segments are growing at explosive rates while others stagnate.

### **2.1. The Macro-Economic Context of 2026**

The economic backdrop of 2026 is characterized by a tentative stabilization of global inflation and a return to moderate growth, though significant geopolitical friction remains. Inflation rates, which had peaked dramatically in previous years—reaching near 300% in hyper-inflationary regions like Argentina—are projected to stabilize significantly, falling to approximately 13.7% in those high-volatility zones and stabilizing near 2% in developed economies.8 This stabilization is critical for the consumer health-tech market. It signals a restoration of purchasing power for the global middle class, allowing for the reallocation of disposable income toward "discretionary necessities"—a category where preventive health tools increasingly sit.  
However, the trade environment has become more hostile. Significant barriers to trade, particularly those erected by the United States, have disrupted physical supply chains and created volatility in hardware markets.8 This macro-trend heavily favors digital goods and software services. Unlike physical medical devices or supplements, which face tariff wars and logistics bottlenecks, pure software tools face minimal friction in cross-border distribution. For a France-based developer, this means the global market remains accessible, provided the software adheres to data sovereignty laws.  
The "wellness" economy has decoupled from general economic stagnation. By 2025, the sector was already valued at $6.8 trillion, growing 35% since 2019 and outpacing broader economic indicators.2 This growth is not evenly distributed. The "luxury" segment of wellness is contracting as aspirational consumers pull back, but the "performance" and "medical" segments are expanding. Consumers are trading down from expensive retreat-based wellness to high-efficacy at-home tools and diagnostics.9 This shift creates a vacuum for affordable, high-utility software that helps users manage their health without the premium price tag of luxury concierge services.

### **2.2. User Segmentation: Who is Paying?**

The analysis identifies three primary user segments that are currently spending money and are underserved by existing tech giants.

#### **2.2.1. The "GLP-1 Initiate" (The Hyper-Growth Segment)**

This is the single most disruptive cohort in the 2026 health landscape. The widespread adoption of GLP-1 receptor agonists (e.g., Semaglutide, Tirzepatide) for obesity and diabetes has created a massive demographic of users who are medically treating metabolic conditions but require entirely new digital tools.2

* **Behavioral Shift:** These users are not "dieting" in the traditional sense. Their appetite is chemically suppressed, altering their fundamental relationship with food. They do not need to count calories to restrict intake; rather, they struggle to eat *enough* to prevent sarcopenia (muscle wasting) and malnutrition.10  
* **Pain Points:** Generic apps like MyFitnessPal are ill-suited for this group because they gamify calorie reduction. GLP-1 users need to track *protein density*, *hydration* (to prevent renal stress), and *side effects* (nausea, constipation) relative to their injection cycle.11  
* **Spending Power:** High. These users are often paying $500–$1,000/month for medication (if uninsured) or significant copays. Investing an additional $5–$10/month for software that maximizes the safety and efficacy of this expensive drug is a rational, low-friction purchase.12

#### **2.2.2. The "Bio-Optimizer" (The High-LTV Segment)**

Formerly known as "biohackers," this group has graduated from fringe experimentation to mainstream "quantified self" practice. They are no longer just tech executives but include performance-focused individuals across all demographics.

* **Behavioral Shift:** They engage in "stacking" interventions—supplements (NMN, Resveratrol), thermal therapies (sauna), and advanced diagnostics (biological age clocks, continuous glucose monitoring).3  
* **Pain Points:** They are drowning in disconnected data. They possess sleep data from Oura, workout data from Garmin, nutritional data from Cronometer, and biological data from blood tests (Quest/LabCorp). They lack a "unified dashboard" that correlates these inputs to answer the question: "Did my new magnesium supplement actually improve my deep sleep?".4  
* **Spending Power:** Very High. They pay for expensive diagnostics and are willing to pay for "Pro" software that offers raw data access and interoperability.13

#### **2.2.3. The "Sandwich Generation" Caregiver**

This segment includes adults aged 40-60 who are simultaneously managing their own health and the care of aging parents.

* **Behavioral Shift:** With the 50+ population generating a third of GDP 15, "AgeTech" is a booming sector. However, the burden of care often falls on family members who must navigate fragmented medical systems.  
* **Pain Points:** The primary crisis is the fragmentation of medical records. A caregiver often manages patient portals for three different specialists, plus their own data. They need aggregation tools to track medication adherence, vitals, and appointment histories across multiple providers.15  
* **Spending Power:** Moderate to High, driven by the acute need to reduce administrative burden and anxiety. They value simplicity, privacy, and "family sharing" features.

### **2.3. The Underserved Gap: The "Solo" Software Ecosystem**

While enterprise healthcare is flooding with venture capital, it remains a graveyard for small startups due to long sales cycles and regulatory inertia.16 The *underserved* market is the direct-to-consumer (DTC) "pro-sumer" space.

* **The Gap:** Most consumer apps are either too simple (basic step counters) or too predatory (selling user data). The market lacks "professional grade" tools for individuals.  
* **Opportunity:** A privacy-focused, technical, "power user" toolset. Users are increasingly wary of cloud-based health apps due to privacy leaks and data selling.17 A "Local-First" software model—where data stays on the user's device—is a massive differentiator in 2026, appealing to the privacy-conscious European and North American markets.18

## **3\. User Pain Points & Jobs-To-Be-Done**

To build a viable product, a solo developer must identify problems that are frequent, painful, and poorly solved by incumbents. The research highlights a landscape where users have access to more health data than ever before, yet suffer from less clarity and control.

### **3.1. The "Interoperability Hell" of Wearables**

Despite the dominance of Apple Health and Google Health Connect as centralized hubs, data export and granularity remain major friction points for advanced users.

* **Apple Health Export Failures:** Users consistently report that the native export feature in Apple Health produces massive, unreadable XML files. These exports often fail to complete or crash devices due to size, and the data structure is hostile to non-developers.4 Users want simple CSV or JSON exports to run their own analysis in Excel or Python but are forced to use third-party tools that are often buggy or incomplete.21  
* **Walled Gardens:** Users of premium devices like Oura rings express frustration that data syncing is often incomplete or unidirectional. For instance, while sleep data might sync to Apple Health, granular "readiness" scores or raw HRV beat-to-beat data often do not, preventing users from correlating this data with other inputs.22  
* **Job-To-Be-Done:** "Liberate my data from proprietary silos so I can analyze it myself." The user wants to own their data, not rent access to it.

### **3.2. The "Medical Record Black Box"**

The digitization of healthcare has ironically created more work for patients. Lab results and medical reports are often delivered as PDFs via disjointed portals.

* **The PDF Problem:** To track a specific biomarker—such as Ferritin or hs-CRP—over a five-year period, a user currently has to manually download dozens of PDFs from different labs (e.g., Quest, LabCorp, hospital portals), find the relevant value, and type it into a spreadsheet. This process is tedious, error-prone, and discourages longitudinal tracking.24  
* **Lack of Normalization:** Even if users extract the data, labs use different reference ranges and units (e.g., mg/dL vs. mmol/L). A layperson cannot easily compare a 2022 result from one lab with a 2026 result from another without performing complex conversions.  
* **Job-To-Be-Done:** "Turn this pile of PDF medical reports into a clean, normalized timeline of my health without requiring manual data entry."

### **3.3. The "Subscription Fatigue" & Privacy Anxiety**

By 2026, the subscription model for every minor utility has caused significant consumer backlash.

* **Predatory Billing:** Users report "scam-like" behaviors from major health apps like Noom, where cancellation is intentionally difficult and billing continues unexpectedly.25 This has created a deep distrust of subscription-based health apps.  
* **Data Trust Crisis:** There is a growing segment of privacy-conscious users who refuse to use cloud-based health apps because they know their biometric data is being aggregated, sold to insurers, or is vulnerable to breaches.18 This is particularly acute for sensitive data regarding mental health, fertility, and medication usage.  
* **Job-To-Be-Done:** "Track my health metrics without a monthly fee and without sending my private biological data to a server I don't trust."

### **3.4. The GLP-1 "Blind Spot"**

As noted in the market discovery, GLP-1 users have distinct needs that current calorie trackers fail to meet.

* **Muscle Mass Anxiety:** A major side effect of rapid weight loss on GLP-1s is the loss of lean muscle mass. Users are desperate to track *body composition* and *protein intake* specifically, rather than just weight or generic calories.10  
* **Symptom Correlation:** Users need to correlate injection sites and dosages with side effects. Questions like "Do I get more nausea when I inject in the stomach versus the thigh?" require a tracker that supports "injection site rotation" logic—a feature absent in generic health apps.11  
* **Job-To-Be-Done:** "Help me optimize my medication protocol to lose fat, preserve muscle, and minimize side effects."

## **4\. Tooling & Technology Opportunities**

For a solo developer with expertise in OCR, AI/ML, and data pipelines, the technological landscape offers powerful leverage points. The key strategic move is to adopt a **Local-First** architecture, which solves the privacy and cost problems simultaneously while enabling high-performance user experiences.

### **4.1. Local-First Architecture (The Solo Dev Superpower)**

Building a cloud-based health app requires HIPAA/GDPR compliant servers, expensive security infrastructure, and ongoing DevOps. A **Local-First** app stores data primarily on the user's device, syncing only via the user's own cloud (e.g., iCloud) or peer-to-peer.

* **Technology Stack:**  
  * **Database:** **SQLite via WebAssembly (WASM)** or **RxDB**. Research indicates that SQLite WASM allows full relational SQL databases to run in the browser or on mobile devices with near-native performance, utilizing the Origin Private File System (OPFS) for persistence.19 **RxDB** offers a reactive, offline-first database that syncs well with React Native/Flutter, allowing for complex queries and real-time UI updates without a backend.27  
  * **Strategic Advantage:** This architecture incurs **$0 in server costs** for data storage. The developer does not pay to host terabytes of user medical records. Furthermore, it allows the developer to truthfully claim "We cannot see your health data," a massive marketing advantage in the privacy-sensitive EU market.7

### **4.2. Medical Document Parsing (OCR \+ LLM Pipeline)**

The automated extraction of structured data from unstructured medical records is a high-value, technically difficult problem that is underserved by current consumer tools.

* **The Pipeline Opportunity:**  
  * **Preprocessing:** Using libraries like **OpenCV** to de-skew, binarize, and denoise images is critical for handling user-uploaded photos of crumpled lab reports.24  
  * **OCR:** While **Tesseract** is the open-source standard, it often struggles with complex table layouts. For a mobile-first approach, leveraging on-device vision frameworks (Apple Vision Framework or Android ML Kit) provides high-accuracy, free, and private OCR.24  
  * **Normalization (The "Magic" Layer):** This is where AI/ML provides leverage. A solo dev can use a small, optimized Large Language Model (LLM)—such as a quantized **Llama-3-8B** or **Phi-3** running locally on the device—to parse the OCR text. This model can map non-standard terms (e.g., "Hgb") to standard ontologies like **LOINC** codes and normalize units.29  
  * **Gap:** Existing open-source tools like "Surya" are powerful for general document layout analysis but lack the specific medical ontology training required to interpret lab values correctly.30 A tool that bridges this gap—mapping OCR output to a standardized medical schema—would be incredibly valuable.

### **4.3. Data Aggregation & "The Quantified Self" Dashboard**

* **Data Ingestion:** Mobile apps built with **React Native** or **Flutter** can natively access Apple Health (HealthKit) and Google Health Connect APIs.  
* **The Missing Link:** A "Connector" that pulls passive data from these hubs and combines it with manual logs (subjective mood, medication) and parsed OCR data into a single, queryable **SQLite** database.  
* **Visualization:** Libraries like **D3.js** or **Victory Native** can render long-term trends locally. The opportunity is to provide *correlational* analysis (e.g., "Show me my HRV on days I took Magnesium vs days I didn't")—a level of insight that Apple Health generally fails to provide.4

## **5\. Regulation-Aware Opportunity Mapping**

Navigating the regulatory environment is critical. A solo developer cannot afford a CE Mark audit or FDA 510(k) clearance process. Success depends on building strictly within the "safe zones" of regulation.

### **5.1. EU Medical Device Regulation (MDR) \- Rule 11**

The European Union has strict regulations regarding medical software. Under **MDR Rule 11**, software is classified as a medical device (Class IIa or higher) if it "provides information which is used to take decisions with diagnosis or therapeutic purposes".31

* **The Danger Zone:** Any app that calculates a dosage (e.g., "Take 2 units of insulin") or offers a diagnostic flag (e.g., "Your heart rate indicates AFib") is a medical device. This requires Notified Body audits and is effectively impossible for a solo dev to maintain legally.  
* **The Safe Zone:** Tools that act as "Digital Notebooks" or "Retrospective Trackers" are generally exempt or fall into Class I (low risk). The key is to provide *information* without *interpretation*. Displaying a graph of heart rate is safe; calculating a risk score based on that graph is risky.32  
* **Strategy:** Frame the tool explicitly as a "wellness" and "tracking" utility. Avoid all predictive and prescriptive claims. Use disclaimers effectively, but do not rely on them as a shield against functional non-compliance.

### **5.2. FDA "General Wellness" Policy (USA)**

The US regulatory environment is more permissible for low-risk apps. The FDA exercises "enforcement discretion" for **"General Wellness"** products.33

* **Scope:** Apps that encourage a general state of health (weight management, physical fitness, relaxation, sleep management) or help users self-manage chronic diseases *without* providing specific treatment advice are generally not regulated as medical devices.  
* **Opportunity:** This allows a developer to be more aggressive with features in the US market. Features like "Lifestyle Scores," "Readiness Metrics," or "Nutritional Scoring" are viable, provided they do not claim to treat or diagnose specific diseases.

### **5.3. GDPR & Data Privacy (EU Focus)**

* **The Trap:** Storing health data (classified as "Special Category Data" under GDPR Art. 9\) on a central server imposes massive liability. It requires a Data Protection Officer (DPO), explicit consent management, and strict security protocols.35  
* **The Local-First Exemption:** If the app architecture is **Local-First**, meaning the developer *never* possesses the data on their servers, the developer is not a "Data Controller" or "Data Processor" in the traditional sense regarding that personal data. The processing happens entirely on the user's device. While the developer must still practice "Privacy by Design," this architecture significantly reduces the compliance burden and liability associated with data breaches.36 This is the only viable path for a solo developer to handle medical data globally without a legal team.

### **5.4. "Research Use Only" (RUO) Limitations**

* **Warning:** Some developers attempt to bypass regulation by labeling apps "For Research Use Only" (RUO). The analysis indicates this is legally ineffective for consumer-facing products.37 If a product is marketed to consumers for a medical purpose, a disclaimer will not protect the developer. The *intended use* must be non-medical (informational, educational, or wellness-focused).

## **6\. Competitive Landscape: Patterns of Failure and Success**

Analyzing the current market reveals distinct patterns that a solo developer can exploit. The incumbents are making strategic errors that create openings for agile, niche competitors.

### **6.1. Pattern 1: The "Subscription Fatigue" Revolt**

* **Observation:** Major players like **Noom**, **WeightWatchers**, **Oura**, and **Whoop** aggressively push subscription models ($6–$50/month). Consumers are increasingly hostile to this "rent-seeking" behavior, especially for apps that offer static utility (e.g., a calorie counter) rather than ongoing service.25  
* **Opportunity:** **The One-Time Purchase Model.** A solo developer does not need recurring revenue to support a massive sales team or VC returns. Selling a high-quality, "Pro" app for a one-time fee of $29.99 or $49.99 is a massive marketing differentiator. For a solo dev, 1,000 sales at $50 ($50,000) is significant revenue; for a VC-backed company, it is a rounding error. This economic asymmetry allows the indie developer to out-price incumbents while still being profitable.

### **6.2. Pattern 2: The "All-in-One" Bloat**

* **Observation:** Apps like **MyFitnessPal** and **Samsung Health** try to be everything to everyone—social network, coaching platform, meal logger, and workout tracker. They become bloated, slow, and unfocused.17  
* **Opportunity:** **Niche Excellence (The Unix Philosophy).** Build a tool that does *one thing* exceptionally well. An app dedicated *exclusively* to parsing blood test PDFs, or *exclusively* to tracking GLP-1 injection sites, can offer a superior user experience (UX) to a "super-app" where these features are buried five menus deep.

### **6.3. Pattern 3: The "Data Silo" & Lack of Trust**

* **Observation:** Incumbents like **Oura** and **Noom** hold data hostage to keep users in their ecosystem. They make export difficult and often sell aggregated data to third parties, eroding user trust.18  
* **Opportunity:** **Radical Interoperability.** Build tools that act as "Universal Adapters." A tool's primary value proposition can be its ability to read from anywhere (PDF, HealthKit, CSV) and write to anywhere (CSV, JSON, Excel). Positioning the product as "Your Data, Your Device" builds immediate trust with the high-value "Bio-Optimizer" segment.

## **7\. Synthesis & Recommendations**

Is the longevity space worth entering globally as a solo developer?  
Yes. The market is growing structurally, the user base is increasingly sophisticated, and the current incumbents are failing to provide the privacy, interoperability, and granular data control that "Pro-sumer" users demand. The economic friction of 2026 (tariffs/inflation) actually favors lean, software-only businesses that do not rely on complex hardware supply chains.  
**Strategy:** Adopt a **"Micro-SaaS" / "Indie App"** model. Avoid building a platform or a regulated medical device. Build high-utility **tools** that solve specific data frictions. Focus on the "Pro-sumer" segments (Biohackers, GLP-1 users) who value data ownership and are willing to pay upfront for quality software.

### **Recommendation 1: "The GLP-1 Companion Pro" (Niche Tracker)**

* **Target User:** Individuals on semaglutide/tirzepatide (Ozempic/Mounjaro) who are data-driven but frustrated by generic calorie apps that nag them to eat less when they are already struggling to eat.  
* **Core Problem Solved:** Managing the unique lifestyle of GLP-1 therapy: prioritizing **protein** (to save muscle), tracking **injection sites** (to minimize side effects), and monitoring **hydration** (to prevent renal issues).  
* **The Product:** A privacy-first, local-data mobile app.  
  * *Features:* Visual body map for logging injection sites (thigh/arm/stomach) with "rotation" reminders. A "Protein-First" macro logger that deprioritizes calorie counting. A side-effect correlation engine ("Do I get more nausea when I inject in the stomach?"). Muscle mass estimator (via impedance scale data import).  
  * *Tech:* React Native \+ SQLite (Local). No server costs.  
  * *Why Now:* The GLP-1 market is exploding (30-50M users in the US alone), and generic apps like WeightWatchers are pivoting too slowly or clumsily.39  
  * *Solo Dev Win:* Niche enough to be ignored by Apple/Google, specific enough to charge a premium one-time fee ($30 lifetime).

### **Recommendation 2: "Bio-Vault" (The Medical Data Normalizer)**

* **Target User:** Biohackers, chronic illness patients, and caregivers managing complex medical histories.  
* **Core Problem Solved:** "I have 10 years of blood tests trapped in 20 different PDFs from 3 different labs. I can't see the trend of my inflammation markers."  
* **The Product:** A desktop/mobile "OCR-to-Graph" tool.  
  * *Features:* Drag-and-drop PDF/Image import. On-device OCR \+ LLM parsing to extract test names, values, units, and reference ranges. Auto-normalization (converting all units to a standard). Beautiful longitudinal graphing. Export to clean CSV/JSON.  
  * *Tech:* Python backend (wrapped in a desktop Electron app) or robust mobile OCR pipeline using on-device vision frameworks. Use a small, local LLM for parsing to ensure privacy and GDPR compliance.  
  * *Why Now:* Users are accumulating massive amounts of data but have no tools to visualize it. Current solutions (InsideTracker) are expensive services ($500+) that require buying *their* tests.  
  * *Solo Dev Win:* High technical barrier to entry (OCR/Parsing is hard) reduces competition. High value \= high price point.

### **Recommendation 3: "The Universal Health Exporter" (Utility Tool)**

* **Target User:** The "Quantified Self" enthusiast and data hoarder.  
* **Core Problem Solved:** "Apple Health and Oura own my data. I want it in a SQL database or CSV to analyze in Excel/Python."  
* **The Product:** A bridge utility.  
  * *Features:* Deep integration with HealthKit/Google Health Connect. Reads *all* data types (including obscure ones like HRV beat-to-beat data). Exports to CSV, JSON, and SQLite formats. Automated background export.  
  * *Tech:* Swift/Kotlin native development for maximum API access.  
  * *Why Now:* Privacy concerns and "walled gardens" are increasingly frustrating advanced users.4  
  * *Solo Dev Win:* Pure utility. Low maintenance once built. "Set and forget" revenue.

### **Recommendation 4: "Longevity Protocol Manager" (Behavioral Tool)**

* **Target User:** Longevity enthusiasts following complex protocols (e.g., Bryan Johnson's Blueprint).  
* **Core Problem Solved:** Adherence. "I need to take 20 supplements, do IR light therapy, fast for 16 hours, and exercise." Generic to-do lists are too simple; calendar apps are too rigid.  
* **The Product:** A protocol-management engine.  
  * *Features:* "Stack" builder (build your routine). Compliance tracking (did I do it?). Inventory management (remind me when to reorder NMN). Outcome correlation (did this stack improve my sleep score?).  
  * *Tech:* Mobile app with rich local database.  
  * *Why Now:* The "supplement stack" market is booming, but adherence tools are lacking.  
  * *Solo Dev Win:* High engagement app. Potential for affiliate revenue (carefully managed) or high-tier premium features for power users.

### ---

**Global Market Data & Trends Snapshot (2025-2026)**

| Metric / Trend | Status 2026 | Implication for Solo Dev |
| :---- | :---- | :---- |
| **Global Inflation** | Stabilizing (\<3% in developed markets) | Consumers have renewed purchasing power for "Pro" apps. |
| **Longevity Economy** | Projected $27 Trillion global impact | Massive TAM, but focus on the "Data/Software" slice. |
| **GLP-1 Adoption** | 30M-50M users in US; rapid EU growth | **Highest Urgency Opportunity.** These users need new tools *now*. |
| **Wearable Tech** | Maturing (Oura 4, Apple Watch X) | Hardware is saturated; **Software/Data Layer** is the opportunity. |
| **Regulation** | EU MDR Rule 11 (Strict), FDA "General Wellness" (Flexible) | Avoid diagnostic claims. Stay in the "Tracking/Wellness" lane. |
| **User Sentiment** | "Subscription Fatigue" & "Privacy Distrust" | Build **One-time Purchase** & **Local-First** apps. |

#### **Sources des citations**

1. 2025 wrap-up: the macroshifts in wellness | 2026 travel trends | Longevity economy: $27 trillion by 2026? \- Global Wellness Summit, consulté le décembre 25, 2025, [https://www.globalwellnesssummit.com/global-wellness-news/2025-wrap-up-the-macroshifts-in-wellness-2026-travel-trends-longevity-economy-27-trillion-by-2026/](https://www.globalwellnesssummit.com/global-wellness-news/2025-wrap-up-the-macroshifts-in-wellness-2026-travel-trends-longevity-economy-27-trillion-by-2026/)  
2. State of Health & Wellness 2025 \- Fitt Insider, consulté le décembre 25, 2025, [https://insider.fitt.co/report/health-wellness-2025-wrapped/](https://insider.fitt.co/report/health-wellness-2025-wrapped/)  
3. The Wellness Revolution: Evidence-Based Insights Into Biohacking Trends In 2025 \- Forbes, consulté le décembre 25, 2025, [https://www.forbes.com/councils/forbesbusinesscouncil/2025/12/15/the-wellness-revolution-evidence-based-insights-into-biohacking-trends-in-2025/](https://www.forbes.com/councils/forbesbusinesscouncil/2025/12/15/the-wellness-revolution-evidence-based-insights-into-biohacking-trends-in-2025/)  
4. Turning Apple Health Data Into Actionable Personal Fitness Insights (Our Hackathon Story), consulté le décembre 25, 2025, [https://www.themomentum.ai/blog/turning-apple-health-data-into-actionable-personal-fitness-insights](https://www.themomentum.ai/blog/turning-apple-health-data-into-actionable-personal-fitness-insights)  
5. Local-first software: You own your data, in spite of the cloud \- Ink & Switch, consulté le décembre 25, 2025, [https://www.inkandswitch.com/essay/local-first/](https://www.inkandswitch.com/essay/local-first/)  
6. How Local-First Development Is Changing How We Make Software | Heavybit, consulté le décembre 25, 2025, [https://www.heavybit.com/library/article/local-first-development](https://www.heavybit.com/library/article/local-first-development)  
7. Why Local-First Software Is the Future and its Limitations | RxDB \- JavaScript Database, consulté le décembre 25, 2025, [https://rxdb.info/articles/local-first-future.html](https://rxdb.info/articles/local-first-future.html)  
8. Global economic outlook 2026 | Deloitte Insights, consulté le décembre 25, 2025, [https://www.deloitte.com/us/en/insights/topics/economy/global-economic-outlook-2026.html](https://www.deloitte.com/us/en/insights/topics/economy/global-economic-outlook-2026.html)  
9. Finding a New Longevity for Luxury | Bain & Company, consulté le décembre 25, 2025, [https://www.bain.com/insights/finding-a-new-longevity-for-luxury/](https://www.bain.com/insights/finding-a-new-longevity-for-luxury/)  
10. GLP-1 support takes over SupplySide Global 2025 | Nutritional Outlook \- Supplement, Food & Beverage Manufacturing Trends, consulté le décembre 25, 2025, [https://www.nutritionaloutlook.com/view/glp-1-support-takes-over-supplyside-global-2025](https://www.nutritionaloutlook.com/view/glp-1-support-takes-over-supplyside-global-2025)  
11. 6 Best GLP-1 Tracking Apps Compared: Which App Actually Works in 2026? \- %, consulté le décembre 25, 2025, [https://learnmuscles.com/blog/2025/11/27/6-best-glp-1-tracking-apps-compared-which-app-actually-works-in-2026/](https://learnmuscles.com/blog/2025/11/27/6-best-glp-1-tracking-apps-compared-which-app-actually-works-in-2026/)  
12. Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend \- Fox Business, consulté le décembre 25, 2025, [https://www.foxbusiness.com/lifestyle/target-beefs-up-protein-supplement-offerings-capitalizing-weight-loss-drug-trend](https://www.foxbusiness.com/lifestyle/target-beefs-up-protein-supplement-offerings-capitalizing-weight-loss-drug-trend)  
13. Longevity Biotech Market Growth: How Fast Is Anti-Aging Science Advancing? (New Stats), consulté le décembre 25, 2025, [https://patentpc.com/blog/longevity-biotech-market-growth-how-fast-is-anti-aging-science-advancing-new-stats](https://patentpc.com/blog/longevity-biotech-market-growth-how-fast-is-anti-aging-science-advancing-new-stats)  
14. GoldAlign 2026 Honest Review Complete (Customer Success Review) With Complaints And Findings, consulté le décembre 25, 2025, [https://foundationrelations.duke.edu/wp-content/uploads/ninja-forms/2/goldalign\_review569.pdf](https://foundationrelations.duke.edu/wp-content/uploads/ninja-forms/2/goldalign_review569.pdf)  
15. TheGerontechnologist: 2025 AgeTech Market Map (8th Edition), consulté le décembre 25, 2025, [https://thegerontechnologist.com/](https://thegerontechnologist.com/)  
16. 8 Predictions for Healthcare 2026: What the Market is Signaling for the Year Ahead, consulté le décembre 25, 2025, [https://hospitalogy.com/articles/2025-12-19/8-predictions-for-healthcare-2026-what-the-market-is-signaling-for-the-year-ahead/](https://hospitalogy.com/articles/2025-12-19/8-predictions-for-healthcare-2026-what-the-market-is-signaling-for-the-year-ahead/)  
17. Is This Just Another Biohacker App, or Real Problem Worth Solving? \- Reddit, consulté le décembre 25, 2025, [https://www.reddit.com/r/roastmystartup/comments/1pnue51/is\_this\_just\_another\_biohacker\_app\_or\_real/](https://www.reddit.com/r/roastmystartup/comments/1pnue51/is_this_just_another_biohacker_app_or_real/)  
18. The privacy nightmare of modern fitness apps: Why is "local-only" so rare? \- Reddit, consulté le décembre 25, 2025, [https://www.reddit.com/r/privacy/comments/1pfssw5/the\_privacy\_nightmare\_of\_modern\_fitness\_apps\_why/](https://www.reddit.com/r/privacy/comments/1pfssw5/the_privacy_nightmare_of_modern_fitness_apps_why/)  
19. Offline-first frontend apps in 2025: IndexedDB and SQLite in the browser and beyond, consulté le décembre 25, 2025, [https://blog.logrocket.com/offline-first-frontend-apps-2025-indexeddb-sqlite/](https://blog.logrocket.com/offline-first-frontend-apps-2025-indexeddb-sqlite/)  
20. Finally built a solution to Apple's broken health data export \- thoughts? : r/QuantifiedSelf, consulté le décembre 25, 2025, [https://www.reddit.com/r/QuantifiedSelf/comments/1nidghn/finally\_built\_a\_solution\_to\_apples\_broken\_health/](https://www.reddit.com/r/QuantifiedSelf/comments/1nidghn/finally_built_a_solution_to_apples_broken_health/)  
21. Lack of exporting options in apple health \- Apple Support Community, consulté le décembre 25, 2025, [https://discussions.apple.com/thread/255135766](https://discussions.apple.com/thread/255135766)  
22. Irritated that Oura activity data doesn't sync to apple health. : r/ouraring \- Reddit, consulté le décembre 25, 2025, [https://www.reddit.com/r/ouraring/comments/1oepymt/irritated\_that\_oura\_activity\_data\_doesnt\_sync\_to/](https://www.reddit.com/r/ouraring/comments/1oepymt/irritated_that_oura_activity_data_doesnt_sync_to/)  
23. What happened to being able to download detailed heart rate data? : r/ouraring \- Reddit, consulté le décembre 25, 2025, [https://www.reddit.com/r/ouraring/comments/1lmu15i/what\_happened\_to\_being\_able\_to\_download\_detailed/](https://www.reddit.com/r/ouraring/comments/1lmu15i/what_happened_to_being_able_to_download_detailed/)  
24. jgarciaporras/Project\_OCR\_Flask: OCR for Medical Reports \- GitHub, consulté le décembre 25, 2025, [https://github.com/jgarciaporras/Project\_OCR\_Flask](https://github.com/jgarciaporras/Project_OCR_Flask)  
25. Noom, Inc. | BBB Reviews | Better Business Bureau, consulté le décembre 25, 2025, [https://www.bbb.org/us/ny/new-york/profile/health-and-wellness/noom-inc-0121-150555/customer-reviews?page=6](https://www.bbb.org/us/ny/new-york/profile/health-and-wellness/noom-inc-0121-150555/customer-reviews?page=6)  
26. LocalStorage vs. IndexedDB vs. Cookies vs. OPFS vs. WASM-SQLite | RxDB \- JavaScript Database, consulté le décembre 25, 2025, [https://rxdb.info/articles/localstorage-indexeddb-cookies-opfs-sqlite-wasm.html](https://rxdb.info/articles/localstorage-indexeddb-cookies-opfs-sqlite-wasm.html)  
27. RxDB as a Database for React Applications, consulté le décembre 25, 2025, [https://rxdb.info/articles/react-database.html](https://rxdb.info/articles/react-database.html)  
28. Alternatives for realtime local-first JavaScript applications and local databases | RxDB, consulté le décembre 25, 2025, [https://rxdb.info/alternatives.html](https://rxdb.info/alternatives.html)  
29. AHMEDELZARIA/lab-result-extraction: An API for extracting patient information from medical documents using machine learning. Designed for accuracy, automation, and easy deployment with Docker. \- GitHub, consulté le décembre 25, 2025, [https://github.com/AHMEDELZARIA/lab-result-extraction](https://github.com/AHMEDELZARIA/lab-result-extraction)  
30. datalab-to/surya: OCR, layout analysis, reading order, table recognition in 90+ languages \- GitHub, consulté le décembre 25, 2025, [https://github.com/datalab-to/surya](https://github.com/datalab-to/surya)  
31. Classification of Medical Devices Under EU MDR (2025) \- Decomplix, consulté le décembre 25, 2025, [https://decomplix.com/medical-device-classification-eu-mdr/](https://decomplix.com/medical-device-classification-eu-mdr/)  
32. MDR Classification Rule 11: The classification nightmare? \- Johner Institute, consulté le décembre 25, 2025, [https://blog.johner-institute.com/regulatory-affairs/mdr-rule-11/](https://blog.johner-institute.com/regulatory-affairs/mdr-rule-11/)  
33. U.S. FDA and CMS Actions on Generative AI-Enabled Mental Health Devices Yield Insights Across AI Product Development \- Sidley Austin LLP, consulté le décembre 25, 2025, [https://www.sidley.com/en/insights/newsupdates/2025/11/us-fda-and-cms-actions-on-generative-ai-enabled-mental-health-devices-yield-insights-across-ai](https://www.sidley.com/en/insights/newsupdates/2025/11/us-fda-and-cms-actions-on-generative-ai-enabled-mental-health-devices-yield-insights-across-ai)  
34. FDA Oversight: Understanding the Regulation of Health AI Tools \- Bipartisan Policy Center, consulté le décembre 25, 2025, [https://bipartisanpolicy.org/issue-brief/fda-oversight-understanding-the-regulation-of-health-ai-tools/](https://bipartisanpolicy.org/issue-brief/fda-oversight-understanding-the-regulation-of-health-ai-tools/)  
35. Recital 52 \- Exceptions to the Prohibition on Processing Special Categories of Personal Data \- GDPR, consulté le décembre 25, 2025, [https://gdpr-info.eu/recitals/no-52/](https://gdpr-info.eu/recitals/no-52/)  
36. Do we avoid GDPR when we leave the data on the device? | Chino.io Blog, consulté le décembre 25, 2025, [https://www.chino.io/post/do-we-avoid-gdpr](https://www.chino.io/post/do-we-avoid-gdpr)  
37. Is it a wellness app or medical device? A critical boundary issue in the smart wearables sector \- Taylor Wessing, consulté le décembre 25, 2025, [https://www.taylorwessing.com/en/insights-and-events/insights/2022/06/is-it-a-wellness-app-or-medical-device---a-critical-boundary-issue-in-the-smart-wearables-sector](https://www.taylorwessing.com/en/insights-and-events/insights/2022/06/is-it-a-wellness-app-or-medical-device---a-critical-boundary-issue-in-the-smart-wearables-sector)  
38. Oura Ring data export (with and without subscription) : r/ouraring \- Reddit, consulté le décembre 25, 2025, [https://www.reddit.com/r/ouraring/comments/1nyza5a/oura\_ring\_data\_export\_with\_and\_without/](https://www.reddit.com/r/ouraring/comments/1nyza5a/oura_ring_data_export_with_and_without/)  
39. Weight Watchers Goes All-In on GLP-1s With App Overhaul \- Athletech News, consulté le décembre 25, 2025, [https://athletechnews.com/weightwatchers-glp-1-app-overhaul/](https://athletechnews.com/weightwatchers-glp-1-app-overhaul/)